Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis
- PMID: 22990018
- PMCID: PMC3501714
- DOI: 10.1182/blood-2012-07-443051
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis
Abstract
The 4Ts is a pretest clinical scoring system for heparin-induced thrombocytopenia (HIT). Although widely used in clinical practice, its predictive value for HIT in diverse settings and patient populations is unknown. We performed a systematic review and meta-analysis to estimate the predictive value of the 4Ts in patients with suspected HIT. We searched PubMed, Cochrane Database, and ISI Web of Science for studies that included patients with suspected HIT, who were evaluated by both the 4Ts and a reference standard against which the 4Ts could be compared. Quality of eligible studies was assessed by QUADAS-2 criteria. Thirteen studies, collectively involving 3068 patients, fulfilled eligibility criteria. A total of 1712 (55.8%) patients were classified by 4Ts score as having a low probability of HIT. The negative predictive value of a low probability 4Ts score was 0.998 (95% CI, 0.970-1.000) and remained high irrespective of the party responsible for scoring, the prevalence of HIT, or the composition of the study population. The positive predictive value of an intermediate and high probability 4Ts score was 0.14 (0.09-0.22) and 0.64 (0.40-0.82), respectively. A low probability 4Ts score appears to be a robust means of excluding HIT. Patients with intermediate and high probability scores require further evaluation.
Figures
Similar articles
-
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.J Thromb Haemost. 2007 Jul;5(7):1373-9. doi: 10.1111/j.1538-7836.2007.02524.x. Epub 2007 Mar 14. J Thromb Haemost. 2007. PMID: 17362241
-
Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial.J Crit Care. 2014 Jun;29(3):470.e7-15. doi: 10.1016/j.jcrc.2014.02.004. Epub 2014 Feb 14. J Crit Care. 2014. PMID: 24726205 Clinical Trial.
-
Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL® HIT-Ab(PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia.Thromb Res. 2017 May;153:108-117. doi: 10.1016/j.thromres.2017.03.010. Epub 2017 Mar 11. Thromb Res. 2017. PMID: 28391124
-
Laboratory diagnosis of heparin-induced thrombocytopenia.Int J Lab Hematol. 2019 May;41 Suppl 1:15-25. doi: 10.1111/ijlh.12993. Int J Lab Hematol. 2019. PMID: 31069988 Review.
-
Developing an algorithm for treating heparin-induced thrombocytopenia.Clin Adv Hematol Oncol. 2004 Apr;2(4):216-22. Clin Adv Hematol Oncol. 2004. PMID: 16163184 Review.
Cited by
-
Evaluation of the rational prescription of linezolid, the prevalence of thrombocytopenia and major drug interactions in patients with cardiovascular diseases: are there any cautions?J Pharm Pharm Sci. 2024 Sep 12;27:13343. doi: 10.3389/jpps.2024.13343. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 39329163 Free PMC article.
-
Electronic alerts to improve management of heparin-induced thrombocytopenia.Res Pract Thromb Haemost. 2024 Apr 30;8(4):102423. doi: 10.1016/j.rpth.2024.102423. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38953054 Free PMC article.
-
How We Interpret Thrombosis with Thrombocytopenia Syndrome?Int J Mol Sci. 2024 May 1;25(9):4956. doi: 10.3390/ijms25094956. Int J Mol Sci. 2024. PMID: 38732176 Free PMC article. Review.
-
Type II Heparin-Induced Thrombocytopenia Manifesting As Cardiac Arrest Following Intravenous Heparin Bolus During an Elective Procedure: A Case Report and Literature Review.Cureus. 2024 Mar 27;16(3):e57072. doi: 10.7759/cureus.57072. eCollection 2024 Mar. Cureus. 2024. PMID: 38681320 Free PMC article.
-
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.JAMA Netw Open. 2024 Mar 4;7(3):e243786. doi: 10.1001/jamanetworkopen.2024.3786. JAMA Netw Open. 2024. PMID: 38530310 Free PMC article.
References
-
- Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68(1):95–96. - PubMed
-
- Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71(2):247–251. - PubMed
-
- Cuker A, Cines DB. How I treat heparin-induced thrombocytopenia. Blood. 2012;119(10):2209–2218. - PubMed
-
- Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997;127(9):804–812. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
